Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 14
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (269)
- Volume 16, 2024 (2)
- Volume 15, 2023 (12)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 14, 2022
Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice [Response to Letter]
Mengesha AK, Birru EM, Adugna M
Clinical Pharmacology: Advances and Applications 2022, 14:113-114
Published Date: 8 December 2022
A Response to Article “Anti-Diarrheal Activity of Hydromethanolic Crude Extract and Solvent Fractions of Acacia Seyal (Fabaceae) Roots in Mice” [Letter]
Panjaitan NSD, Fitriana F, Handayani S
Clinical Pharmacology: Advances and Applications 2022, 14:111-112
Published Date: 29 November 2022
Anti-Diarrheal Activities of Hydromethanolic Crude Extract and Solvent Fractions of Acacia seyal (Fabaceae) Roots in Mice
Mengesha AK, Birru EM, Adugna M
Clinical Pharmacology: Advances and Applications 2022, 14:99-110
Published Date: 15 November 2022
Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
Oliver MB, Vaughn BP
Clinical Pharmacology: Advances and Applications 2022, 14:91-98
Published Date: 23 September 2022
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
Stefanovic F, Gomez-Caminero A, Jacobs DM, Subramanian P, Puzanov I, Chilbert MR, Feuerstein SG, Yatsynovich Y, Switzer B, Schentag JJ
Clinical Pharmacology: Advances and Applications 2022, 14:69-90
Published Date: 10 August 2022
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Alorfi NM, Algarni AS
Clinical Pharmacology: Advances and Applications 2022, 14:61-67
Published Date: 3 August 2022
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
Kosmas CE, Bousvarou MD, Sourlas A, Papakonstantinou EJ, Peña Genao E, Echavarria Uceta R, Guzman E
Clinical Pharmacology: Advances and Applications 2022, 14:49-59
Published Date: 16 July 2022
Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
Ahmedalgabri RHM, Omer T, Zarroug F, Elkhawad AO, Noma M
Clinical Pharmacology: Advances and Applications 2022, 14:37-47
Published Date: 5 April 2022
Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia
Alorfi N, Ashour A
Clinical Pharmacology: Advances and Applications 2022, 14:27-35
Published Date: 5 April 2022
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
Inaishi J, Saisho Y
Clinical Pharmacology: Advances and Applications 2022, 14:19-26
Published Date: 21 February 2022
Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review
Zewdie KA, Hailu HG, Ayza MA, Tesfaye BA
Clinical Pharmacology: Advances and Applications 2022, 14:11-17
Published Date: 21 February 2022
Current Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
Rijavec E, Biello F, Indini A, Grossi F, Genova C
Clinical Pharmacology: Advances and Applications 2022, 14:1-9
Published Date: 20 January 2022